ULTOMIRIS
Drug timelines are a Plus or Pro feature.
27 regulatory and trial events tracked for ULTOMIRIS, covering 2018-12-21 to 2026-07-21. Get the full timeline:
Most recent: EMA Authorised: Ultomiris (ravulizumab) — Alexion Europe SAS
27 regulatory and trial events tracked for ULTOMIRIS, covering 2018-12-21 to 2026-07-21. Get the full timeline:
Most recent: EMA Authorised: Ultomiris (ravulizumab) — Alexion Europe SAS